Understanding the catalytic mechanism of glycogen phosphorylase has applications in developing therapeutic agents for diabetes and metabolic syndrome. Inhibitors of this enzyme are being explored as potential drugs to reduce blood glucose levels by limiting glycogen breakdown.
